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The redox protein p66shc mediates 
cochlear vascular dysfunction and 
transient noise-induced hearing 
loss
A. R. Fetoni1,*, S. L. M. Eramo2,*, F. Paciello1, R. Rolesi1, D. Samengo3, G. Paludetti1, 
D. Troiani2,† & G. Pani3,†
p66shc, a member of the ShcA protein family, is essential for cellular response to oxidative stress, and 
elicits the formation of mitochondrial Reactive Oxygen Species (ROS), thus promoting vasomotor 
dysfunction and inflammation. Accordingly, mice lacking the p66 isoform display increased resistance 
to oxidative tissue damage and to cardiovascular disorders. Oxidative stress also contributes to noise-
induced hearing loss (NIHL); we found that p66shc expression and serine phosphorylation were induced 
following noise exposure in the rat cochlea, together with markers of oxidative stress, inflammation 
and ischemia as indicated by the levels of the hypoxic inducible factor (HIF) and the vascular endothelial 
growth factor (VEGF) in the highly vascularised cochlear lateral region and spiral ganglion. Importantly, 
p66shc knock-out (p66 KO) 126 SvEv adult mice were less vulnerable to acoustic trauma with respect to 
wild type controls, as shown by preserved auditory function and by remarkably lower levels of oxidative 
stress and ischemia markers. Of note, decline of auditory function observed in 12 month old WT controls 
was markedly attenuated in p66KO mice consistent with delayed inner ear senescence. Collectively, we 
have identified a pivotal role for p66shc -induced vascular dysfunction in a common pathogenic cascade 
shared by noise-induced and age-related hearing loss.
Sensory neural hearing loss by exposure to noise or ototoxic drugs and age related hearing loss (ARHL) are the 
most common pathologies of the inner ear, which impair significantly the quality of life. Reactive Oxygen Species 
(ROS) are recognized as major contributors to the onset and progression of these communication disorders. 
In particular, the main underlying molecular mechanisms include free-radical formation and oxidative stress, 
however, reduced cochlear blood flow and inflammation have also emerged as key processes in recent years1–4. 
Oxidative stress results from an imbalance between ROS production and the cellular antioxidant defense system. 
This condition represents the main mechanism of cochlear damage following noise over-exposure and ARHL3,5, 
beside representing the leading pathway of several neurodegenerative diseases6. Under stress conditions, ROS lev-
els increase and, because of their high reactivity, participate in a variety of chemical reactions leading to cell dam-
age, necrosis, and apoptosis via oxidation of lipids, proteins, and DNA7. Mitochondria are generally considered 
to be the primary source of ROS as well as the major target for their damaging effects8,9. With this respect, several 
studies have revealed the role of the p66shc adaptor protein in ROS production within the mitochondria and 
its involvement in various oxidant-related pathologies10–12. Normally p66shc resides in the cytosol, while under 
oxidative stress (e.g., under ischemia/reperfusion insult), it is translocated trough a PKC-dependent mechanism 
in the mitochondria where it serves as an important source of ROS. In mitochondria, this adapter molecule has 
been suggested to function as a redox enzyme possibly oxidizing cytochrome c and generating H2O2 through its 
amino-terminal portion that displays sequence similarity with certain redox enzymes13–15. Accordingly, in cells 
lacking the p66 gene, free radicals are reduced and tolerance to oxidative stress is increased; moreover, knock-out 
mice lacking the p66shc gene survive acute exposure to the radical generator Paraquat10, and, in agreement with 
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the “free radical theory of ageing”, are resistant to several age-related diseases, including obesity16,17, atheroscle-
rosis18,19, ischemic injury20,21, and diabetes17,22. Importantly, much of the detrimental and ageing-accelerating 
activity of p66shc appears to involve the (micro and macro) vasculature, where p66-dependent ROS (as in the 
context of diabetic hyperglycemia) promote endothelial damage and dysfunction by reducing nitric oxide (NO) 
bioavailability, compromising vasomotor function and participating in proinflammatory cascades that lead to 
endothelium activation and enhanced leukocyte adhesion and atherogenesis23,24.
Cochlea hosts a complex vascular organization, comprising at least two distinct capillary networks located, 
respectively, within the Spiral ganglion (SGNs) and the stria vascularis (StV). In particular the capillaries of the 
StV form a blood-labyrinth barrier that regulates ion transport and fluid balance in the inner ear and is crucial 
for maintaining the endocochlear potential and by extension the sensory hair cell function25–28. Accordingly, 
vasculature-centered pathologic processes such as reduced blood flow, hypoxia and inflammation contribute to 
hearing impairment following acoustic trauma and most likely also to strial presbycusis29–31
The emerging role of p66shc in age-related disorders associated with increased levels of oxidative stress and 
vascular/endothelial dysfunction, along with the strong mechanistic commonalities between hearing impairment 
occurring with age and auditory defects by acoustic trauma or chemical toxicity, prompted us to investigate the 
potential involvement of p66shc in noise-induced hearing loss (NIHL) in the rat. By a combination of functional, 
morphological and biochemical studies, and taking advantage of the availability of a p66 deficient mouse strain, 
we collected here evidence for a novel p66shc-centered pathogenic pathway in NIHL involving cochlear oxida-
tive stress, inflammation and impaired blood flow, the latter revealed by a robust hypoxic/angiogenic response. 
These findings, while provide ground for novel preventive and therapeutic approaches against common forms of 
hearing loss, add NIHL and ARHL to the list of p66shc-related disorders, likely through the same vascular mecha-
nisms that reportedly underlie p66shc roles in ischemic, atherosclerotic and diabetic vascular damage and in whole 
organism senescence23.
Results
Noise-induced hearing loss is accompanied by oxidative stress and by induction and phospho-
rylation of p66shc in the rat cochlea. In order to confirm the role of oxidative stress in NIHL and to gain 
initial insight in the potential role of p66shc in this process we subjected Wistar rats to a paradigm of acoustic 
insult that models NIHL32,33. We recorded ABRs (Auditory Brainstem Responses) before and 1, 3, 7 and 21 days 
after noise exposure; in this experimental setting, loss of auditory function was quantified as threshold shift, i.e. 
the difference between the pre-noise and post-noise exposure value of auditory threshold for a given frequency. 
In noise-exposed rats (Fig. 1A), at day 1 after acoustic trauma the temporary threshold shift was elevated of about 
30–40 dB for mid and high frequencies and of 15 dB for the low frequencies, with the greatest hearing loss occur-
ring in the 12–24 kHz range (Fig. 1B). Three days after acoustic trauma, there was a small partial recovery in the 
Noise group and the average of threshold shift decreased approximately of 5 dB for all frequencies. At day 7, an 
additional 10 dB recovery of thresholds was detected involving all frequencies with a greater attenuation in the 
mid and high frequency range. At day 21 measurement, thresholds continued to recover; however, as previously 
reported32,33, noise-exposed rats showed a residual permanent threshold shift of about 10–25 dB for low and mid/
high frequencies respectively, (Fig. 1A).
To further characterize the functional effect of exposure to noise, we studied the latency/intensity and ampli-
tude/intensity curves of ABR waveforms at 16 kHz. The ABR latency provides insight on the transmission times 
along the auditory pathway, whereas ABR amplitude is a function of neural synchrony and of the number of neu-
ral units firing; their analyses can therefore provide diagnostic information on these neural functions. Evaluations 
of ABR P1 wave at day 1 (Fig. 1C) showed increased latency and decreased amplitude, consistent with significant 
impairment of the auditory function at this early time point after acoustic trauma.
Based on the above findings, we used the lipid peroxidation marker 8-isoprostane and the superoxide marker 
DHE (Dihydroethidium) to evaluate the levels of oxidative stress in the cochlea (HCs, SGNs and stria vascula-
ris, Fig. 1D) 24 h after noise exposure (Fig. 1E–H), coincident with the maximum auditory defect. As shown in 
Fig. 1E,G, 8-isoprostane and DHE signals, barely detectable in the unexposed cochleae, became intense in all 
cochlear regions in noise-exposed animals (Fig. 1F,H and optical density in Fig. 1I), consistent with accumulation 
of ROS and oxidative damage in these structures.
In order to establish an initial correlation between noise-induced cochlear oxidative stress and p66shc we 
immunostained inner ear sections isolated after 24 hours of noise exposure or sham treatment for p66shc (Fig. 1J,K) 
or its ser-36 phosphorylated form (ser36-P-p66shc) (Fig. 1L,M). Immunofluorescence analysis displayed a faint 
staining for p66shc (Fig. 1J and optical density in Fig. 1N) in the untreated group and a strong signal increase in 
the cochlea of exposed animals, in particular in the stria vascularis and SG (Fig. 1K). Overlapping results were 
obtained with ser36-P-p66, whose intensity and distribution mirrored that of total p66shc (Fig. 1L,M and optical 
density in Fig. 1O). Accumulation of phosphorylated (i.e. active) p66shc in the cochlea was also confirmed by 
phospho-specific western blot analysis of bulk cochlear homogenates using an anti phospho ser36-p66shc spe-
cific antiserum (Fig. 1P). Band quantification, in particular, revealed for ser-36-p66 an increment of about 30% 
(p < 0.05 by two-tailed t-test) in Noise group compared to control rats (Fig. 1Q). Collectively, these findings 
indicate that p66shc is expressed in the rat cochlea and is induced and phosphorylated in response to an acoustic 
trauma, in a fashion that parallels significant auditory loss and the establishment of intense oxidative stress.
NIHL and oxidative stress are ameliorated in p66shc deficient mice. To establish a mechanistic 
connection between p66shc induction by noise and NIHL, we subjected wild type 129Sv mice and p66-deficient 
(p66KO) mice10 to acoustic trauma and evaluated ABRs at different times as described for rats. Like in rats, the 
greatest hearing loss occurred in the mid-high frequencies range (12–24 kHz). The baseline ABR thresholds (day 0) 
did not differ among the assigned treatment groups (data not shown). At day 1 after noise exposure, the threshold 
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Figure 1. Noise-Induced hearing loss is accompanied by oxidative stress and by activation of p66shc in 
the rat cochlea. (A) ABR averaged threshold shift values (± SEM) in the Noise group (n = 6 rats) showing the 
greatest hearing loss at day 1 (12–20 kHz) and a residual defect (~25 dB) at day 21. (B) Compared threshold 
values before and at day 1 post-noise. (C) Latency and amplitude of P1 wave (16 kHz, 80 dB) at day 1 post-noise. 
(D) representative H&E-stained cryosection displaying the main structures and cell types of the rat cochlea 
(middle turn). (E–H) representative confocal images of 12 μ m-thick rat cochlea cryosections (12 μ m), showing 
enhanced 8-isoprostane (F) and DHE (H) fluorescent signals in oC, SG and StV. Fluorescence accumulation 
indicates increased lipid peroxidation and super-oxide production at day 1 after noise exposure (compare: E–G 
with F–H). (I) quantification of fluorescence signal for 8-isoprostane (blue columns) and DHE (red columns) 
measured by optical density (data are normalized to control). Pictures are representative of two/three sections 
from each of 5 animals/group (right cochleae used for 8-isoprostane; left cochleae for DHE staining). (J–Q) 
The acoustic trauma induces p66shc protein and its ser36 phosphorylated form. (J–M) Increased expression 
of p66shc (compare J with K) and of its phosphorylated form ser36-P-p66shc (compare L with M). Pictures are 
representative of 2–3 sections from each of 5 animals per group (right cochleae: p66shc; left cochleae: ser36-P-
p66shc). (N–O) immunofluorescence analysis of total p66shc and ser36-P-p66shc, respectively. (P) Anti ser36-
P-p66 immunoblot analysis of total cochlear homogenates from control and noise-exposed rats. Relevant 
bands are indicated by arrowhead. (Q) ser36-P-p-66shc band densitometric quantitation confirming increased 
phosphorylation signal in the Noise group. Values are mean ± SD of 2 controls (Ctrl) and 3 trauma-exposed 
(Noise) samples. Blot representative of two/three independent experiments. Statistics: (B,C,I) by two-way 
ANOVA (***p < 0.0001); (N,O) by one-way ANOVA and Q by two-tailed t-test (*p < 0.05; **p < 0.001; 
***p < 0.0001). Scale bar: (E–H) 100 μ m; (J–M) organ of Corti 30 μ m, StV 50 μ m, SGNs 15 μ m. SV: scala 
vestibuli, RM: Reissner membrane, SM: scala media, MCs: marginal cells, ICs: intermediate cells, BCs: basal 
cells, LW: lateral wall, StV: stria vascularis, oC: organ of Corti, SGNs: spiral ganglion neurons, SCs: supporting 
cells, BM: basilar membrane, OHC: outer hair cells, IHC: inner hair cells, ST: scala tympani, LB: limbus.
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Figure 2. NIHL and oxidative stress are ameliorated in p66shc deficient mice. (A,B) ABR averaged threshold 
shift values (± SEM,) in WT Noise (n = 6) and p66KO Noise (n = 6) groups. (C) Overlay of WT Noise and 
p66KO Noise curves at day 1, displaying significant protection (about 40 dB TS) from early NIHL in the latter 
mouse strain. (D) Latency and amplitude of P1 wave at day 1 post-noise as in Fig 1C. (E–L) representative 
confocal images of mouse (6 μ m) cochlear cryosections at day 1 post-noise exposure showing enhanced 
8-isoprostane (F–H) and DHE (J–L) fluorescent signal in multiple cochlear structures (arrows) including oC, 
SG and StV. Fluorescence accumulation in the WT mouse indicates increased lipid-peroxidation and super-
oxide production (arrows) after noise exposure (compare: E–I with F–J). Trauma-induced oxidative stress 
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shift in WT mice was of about 40–60 dB for mid and high frequencies and of 20 dB for the low frequencies, with 
the highest threshold shift being observed at 16 kHz (p < 0.0001) (Fig. 2A). Interestingly p66KO animals recorded 
at the same day appeared remarkably resistant to noise, with an elevation of threshold of only about 15–25 dB 
across all frequencies (Fig. 2B). At 3 and 7 days after noise exposure a prompt recovery of 30–40 dB of threshold 
was detected in WT animals at all frequencies, with a greater attenuation in the mid and high frequency range. At 
day 21 measurement, thresholds continued to recover to reach a permanent shift value of about 5–10 dB for low, 
mid and high frequencies (Fig. 2A). Differences between WT and p66KO mice, evident at day 1 (Fig. 1C), become 
progressively smaller over later measurements, with threshold shift curves superimposable to WT controls at 7 
and 21 days and a very similar (5–10 dB) threshold shift (Fig. 2A,B). Evaluation of ABR P1 wave at day 1 (Fig. 2D) 
showed increased latency and decreased amplitude in WT mice but not in KO, in keeping with the above evidence 
of preserved auditory function after noise exposure in the latter mutant strain.
Prompted by these findings, we compared the two strains for the levels of cochlear oxidative stress 24 h 
after noise exposure. As shown in Fig. 2E–L, 8-isoprostane staining and DHE signal, barely detectable in the 
unexposed cochleae, became intense in all cochlear structures in noise-exposed wild type animals (Fig. 2F,J). 
However, in keeping with functional data, fluorescence increase was markedly attenuated in p66KO exposed 
mice (Fig. 2H,L), suggesting that p66shc is required, to a large extent, for the long reported noise-induced cochlear 
oxidative damage.
Consistent with these findings, and with similar evidence in rats, immunofluorescence analysis of coch-
lear sections from wild type mice confirmed a strong induction of both p66shc (Fig. 2M,N) and ser36-P-p66shc 
(Fig. 2Q,R), especially in the stria vascularis and Spiral ganglion, 24 hours after noise exposure. Importantly, this 
signal was specifically attributable to p66shc, as confirmed by lack of reactivity to either antiserum in the cochleae 
of Ctrl (Fig. 2O,S) and Noise p66 KO animals (Fig. 2P,T). The immunofluorescence data were confirmed by opti-
cal density analyses both for 8-isoprostane and superoxide (Fig. 2U) and for p66shc and ser36-P-p66shc (Fig. 2V,W) 
level.
Noise induces a proinflammatory and proangiogenic response in rat cochlea. Inflammation par-
ticipates in noise-induced hearing loss1,2; moreover, inflammation is a common consequence of tissue oxidative 
damage, and evidence exist that lack of p66shc may protect tissues, at least in part, by reducing damage-associated 
inflammation34,35. To obtain a snapshot of the inflammatory cytokines and factors released in the cochlea in 
response to acute noise injury, cochlear homogenates from sham-and noise-treated rats were interrogated for the 
expression of multiple inflammatory mediators by means of a commercial cytokine array.
Of the 34 factors tested, only 3 (INF gamma, Interleukin 1 alpha, and VEGF) displayed a fold increase > 1.5 
in the noise-exposed sample; conversely, the Ciliary Neurotrophic Factor (CNTF), a trophic molecule poten-
tially implicated in age-related hearing loss36, was markedly decreased (2 fold reduction) by noise (Fig. 3). 
Similarly decreased was the content of Interleukin 10, a cytokine broadly recognized “anti-inflammatory” or 
inflammation-terminating functions37. Overall, this analysis provided evidence for an early proinflammatory 
and angiogenic cochlear response to acute acoustic trauma, to be further investigated in the context of p66shc 
deficiency.
p66shc contributes to cochlear ischemic/angiogenic response to noise. Prompted by the presence 
of VEGF-A among the cochlear cytokines induced by noise, and in order to identify the cochlear structures 
expressing VEGF-A, a series of immunofluorescence studies were performed in rats (Ctrl and Noise-exposed 
Fig. 4A,B,G,H) and in WT and p66KO mice (Ctrl and Noise-exposed, Fig. 4C–F,I–L) 24 h after the acoustic 
insult. In agreement with biochemical analysis of rat cochlear homogenates, noise exposure strikingly increased 
VEGF-A immunoreactivity in all cochlear structures, the stria vascularis displaying, as expected for an angiogenic 
factor, the most evident changes (Fig. 4B,H). Importantly, these changes were blunted in the cochleae of p66KO 
compared to WT mice (Fig. 4D,J,F,L). Quantitative analysis of fluorescence intensity in the stria vascularis and SG 
confirmed that VEGF-A immunostaining is significantly increased by noise both in rat and mouse cochlea, in a 
fashion that requires p66shc and is markedly reduced in p66KO animals (Fig. 4M,N1 and N2).
Since noise insult reportedly compromises cochlear microcirculation38,39, and VEGF expression often occurs 
in response to tissue ischemia/hypoxia through transcriptional upregulation by the hypoxia induced factor 
1 alpha (HIF-1α )40, we also evaluated, at the same time point, the expression of both VEGF-A and the latter 
hypoxic marker in cochlear sections in rats before and 24 h after acoustic trauma (Fig. 4O–T, StV; Fig. 4U–Z, 
is nearly abolished in the cochleae of p66KO mice (compare: G–K with H–L). Pictures are representative of 
two/three sections from each of 5 animals/group (right cochleae used for 8-isoprostane and left ones for DHE 
staining). (M–T) Confocal representative images of cochlear cryosections immune-stained for p66shc (four 
panels M-P on the left) and ser36-P-p66shc (four panels Q–T on the right); (M,O,Q,S) control specimens; 
(N,P,R,T) day 1 after acoustic trauma. Immunostaining for both p66shc and its ser36-phosphorylated form 
is increased by noise in all cochlear structures of WT mice, including StV (panels N and R). No signal is 
detected in the corresponding cochlear structures from p66KO mice, confirming staining specificity (P,T). 
Arrows: OHC; Arrowheads: IHC. (U) quantification of fluorescence signal for 8-isoprostane (blue column) and 
DHE (red column) measured by optical density (data are normalized to control). (V,W) fluorescence signal 
quantitation for p66shc and ser36-P-p66shc respectively. Pictures representative of two-three sections from each 
of 5 animals/group (right cochleae: p66shc; left cochleae: ser36-P-p66shc). Statistics: A-D by two-way ANOVA 
with Tukey’s post-hoc analysis (*p < 0.05; **p < 0.001;***p < 0.0001). (U–W) by two-way ANOVA (*p < 0.05; 
**p < 0.001; ***p < 0.0001). Scale Bars: (E–L) 100 μ m; (M–T) organ of Corti 30 μ m, StV 50 μ m, SGNs 15 μ m.
www.nature.com/scientificreports/
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SGNs). As expected, HIF-1α was nearly undetectable in the cochlea of sham-treated animals (Fig. 4P,V); 
remarkably, however, noise exposure led to a strong increase of HIF-1α immunoreactivity in stria vascularis 
and spiral ganglion neurons (Fig. 4S,Y), specifically in both nuclei and cytosol as shown by Z-stack confo-
cal analyses (Fig. 4S1,Y1). Interestingly, confocal analysis of sections simultaneously stained for HIF-1α and 
VEGF-A (Fig. 4Q,T,W,Z) confirmed that the expression patterns of these two protein species largely overlap 
in noise-exposed samples (compare in Fig. 4Q,W with T,Z), suggesting that they belong to the same hypoxic 
signaling cascade triggered, in highly vascularized areas of the cochlea, by p66shc-dependent oxidative stress and 
microvascular dysfunction.
Delayed ARHL in p66KO mice. Cochlear oxidative damage, inflammation and impaired blood flow are 
also typical features of age-related inner ear degeneration leading to presbycusis30,41,42. Since p66shc deletion delays 
several features of ageing in mice, we asked whether p66KO animals could be protected by ARHL as well as by 
NIHL. To answer this question we performed ABR threshold measurements in WT and p66KO mice at 2, 7, 12 
and 24 month old. WT and p66KO mice of age 2 and 7 month had the same threshold value across the analyzed 
frequencies (about 50 dB at 6 kHz and about 30–35 dB in mid-high frequencies) while, 12 month-old WT mice 
had significantly higher threshold values (65–70 dB across frequencies, Fig. 5A) compared to younger animals. 
Such time-dependent decline of auditory function was however attenuated in p66KO mice of the same age, that 
displayed threshold values 15–30 dB lower than WT controls, with the highest difference (42% amelioration) 
Figure 3. Noise induces a proinflammatory and proangiogenic response in rat cochlea. Bar histogram 
illustrating the differential expression of 34 cytokines in the cochlear homogenates of Noise-exposed and Sham-
treated Wistar rats (pools of 5 cochleae from 5 animals/group), simultaneously evaluated by a commercial 
antibody array. Values are Noise-to-Sham ratios (fold induction if > 1 or fold reduction, i.e. − 1/fold induction, 
if < 1) calculated from duplicate spots for each cytokine. Cytokines displaying a fold induction or a fold 
reduction > 1.5 (with p < 0.05 by t-test) were highlighted in red or green, respectively. Picture representative of 
two independent hybridizations.
www.nature.com/scientificreports/
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observed at 16 kHz (Fig. 5B). 24 month-old mice displayed a further increase in ABR thresholds (up to 80–90 dB 
across frequencies), with no longer difference between the WT and p66KO strains (Fig. 5A).
We further analyzed ABR waves by studying the latency/intensity and amplitude/intensity curves of ABR 
waveforms at 16 kHz in 7, 12 and 24 month old mice (shown in Fig. 5C,D for P1 wave). In keeping with thresh-
old analysis, the WT latency at 12 month age was prolonged about ~1 ms for P1 as compared to p66KO mice 
(Fig. 5C). The WT amplitude rapidly declined with age, and, at 12 month age, was lower about ~300 nV for P1 
as compared to p66KO, in which amplitude values did not significantly change compared to 7 months (Fig. 5D). 
However, at 24 month age there was no amplitude difference between WT and p66KO mice (Fig. 5D). These 
Figure 4. p66shc contributes to a cochlear ischemic/angiogenic response to noise. (A–L) 
immunofluorescence analysis of representative cochlear sections from rats (panels A,B,G,H) and mice (WT and 
p66KO, panels C–F and I–L) revealing robust induction of VEGF-A in the stria vascularis and Spiral ganglion 
neurons (SGNs) 24 hours after noise exposure (compare B,D and H,J with A,C and G,I). VEGF increase by 
acoustic trauma is blunted, although not abolished, in p66KO mice compared to WT animals (compare F,D 
with L,J). Pictures representative of 2–3 sections from each of 5 animals per group. M, N1 and N2: Fluorescence 
quantitation from n = 9 sections/group, confirming VEGF-A increase by noise in both rats and mice and 
partial protection in p66KO animals compared to p66-proficient controls. Data are normalized to control. O 
through Z: Hypoxia Induced factor 1 alpha (HIF-1α ) is induced by noise in the rat cochlea and co-localizes with 
VEGF in stria vascularis (O–T) and spiral ganglion neurons (U–Z). (O,R,U,X) VEGF-A (green fluorescence); 
(P,S,V,Y) HIF-1α (red fluorescence); (Q,T,W,Z) merge. HIF-1α and VEGF are both induced by noise and 
co-localize in all the examined structures. P1, Y1, S1, V1: VEGF activation by HIF was confirmed by confocal 
Z-stack analysis and HIF-1α nuclear translocation was assessed in SGNs and stria vascularis. P1, S1, V1, Y1: 
representative high magnification images of anti-HIF-1α /DAPI double staining and confocal Z-stack analysis 
XZ and YZ (box 1 = DAPI; 2 = HIF-1α ; 3 = merged HIF-1α /DAPI). XZ and YZ cross-sections (referred to 
the dashed lines) show both cytosolic and nuclear increase of HIF-1 α fluorescence signal in noise (S1 and Y1) 
compared to control (P1 and V1) samples. Pictures representative of 2–3 sections from each of 5 rats per group 
(right cochleae for VEGF-A and left cochleae for HIF-1α ). Statistics: M by one-way ANOVA (***p < 0.0001), 
N1 and N2 by two-way ANOVA (*p < 0.05, **p < 0.001, ***p < 0.0001). Scale Bars: in A-F StV 50 μ m, in SGNs 
15 μ m. In O-Y1: StV O-T 50 μ m, P1, S1 20 μ m; SGNs U-Z 15 μ m.
www.nature.com/scientificreports/
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findings suggest an impairment of neural synchrony and/or a decrease in the number of neural unit firing during 
ageing that is similar to that observed in noise-exposed animals43 as shown in Figs 1 and 2. More important, they 
confirm that p66shc deletion delays (but does not prevent) the age-dependent decline of auditory function in 
129SvEv mice, possibly by impinging on the same oxidative and circulatory mechanisms that also underlie NIHL.
Discussion
The main findings of the present study are that: a) p66shc is expressed in multiple structures of rodent (mouse 
and rat) cochlea, and its levels of expression/phosphorylation are increased, especially in the stria vascularis and 
spiral ganglion, 24 hours after the acoustic insult; b) 129SvEv mice lacking the p66shc adapter protein are resistant 
to the transient impairment of auditory function induced by noise in their p66shc-proficient controls; c) the acute 
noise-induced hearing loss is accompanied, in rats and mice, by histochemical and biochemical signs of oxidative 
stress, inflammation and compromised cochlear blood flow, which are absent or attenuated in p66-deficient mice; 
d) the absence of p66shc delays the onset of auditory decline in 129Sv mice, a strain affected by progressive ARHL. 
Collectively, these evidences support a pivotal role for p66shc in a pathogenic cascade shared by two common 
and invalidating auditory disorders, and involving, as key components, oxidative stress and vascular/endothelial 
dysfunction.
We have compared wild type and p66− /− (p66shcKO) mice, both in the 129SvEv background. The inter-
est in this specific strain was also linked to the peculiar susceptibility of 129SvEv mice to NIHL versus ARHL. 
Consistent with literature44,45, we found that the 129SvEv animals were remarkably noise resistant; surprisingly, 
however, we observed in WT mice, but not in p66KO animals, a narrow window of vulnerability to noise expo-
sure during the first 24 hours following acoustic insult. In wild type mice, as well as in Wistar rats, the hear-
ing deficit was associated with evidence of oxidative stress and with increased expression of both p66shc and 
Figure 5. Delayed ARHL in p66KO mice. (A,B) ABR threshold values in dB (mean ± SEM) as recorded at 
2, 7, 12 and 24 month age in WT and p66KO mice. Elevated threshold values at 12 and 24 months indicate 
that auditory function spontaneously declines with age in a fashion that is delayed (difference with WT at 12 
months) but not prevented (no difference at 24 months) in p66KO mice across the analyzed frequencies. (C,D) 
evaluation of neural transmission through ABR latency and amplitude analysis of the waveform P1 at 16 kHz in 
WT and p66KO animals of 7, 12 and 24 month age. In WT mice longer latency and reduced potential amplitude 
over time, two functional correlates of ARHL, are already evident at 12 months, but only appear at 24 month 
in p66KO animals, consistent with delayed hearing loss in this strain. ABR recordings performed in 8 mice 
per group at the different time points. Histogram columns are Mean ± SD. Statistics by three way (A) and two-
way ANOVA (B–D), followed by Tukey’s post-hoc analysis. Asterisks denote significant differences between 
genotype/groups (*p < 0.05, **p < 0.001, ***p < 0.0001).
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ser-36-P-p66 in the stria vascularis, organ of Corti and spiral ganglion neurons. These data underlined a role of 
p66shc in the initial acute phase of noise-induced cochlear damage even in animals showing a resistance to noise 
as determined, at later time points, by normal threshold values at ABR analysis and absence of oxidative stress.
The transient nature of the auditory defect observed in WT animals 24 hours after noise exposure likely 
reflects a short-term functional imbalance rather than a structural damage resulting for instance, from death of 
hairy cells46,47 or loss of fibrocytes in the lateral wall48,49. We propose that such a functional defect resides in the 
establishment of p66shc- and ROS-triggered endothelial dysfunction and in (transiently) compromised cochlear 
blood flow. This idea is consistent with evidence of ROS increase and of p66shc accumulation and phosphorylation 
especially in the stria vascularis, a highly vascularized region of the cochlea whose capillary network underlies the 
blood-labyrinth barrier and participates in the ion fluxes that maintain endocochlear potential and by extension 
neurosensory excitability26,27. Moreover, induction in rats of inflammatory markers (like interleukin 1 alpha) 
known to elicit endothelial activation, and evidence in both rats and mice of elevated VEGF levels following 
noise exposure are consistent with endothelial stress and reduced blood flow leading to cochlear hypoxia31,50. This 
is further corroborated by immunofluorescence detection in the rat cochlea of accumulated Hypoxia Induced 
Factor (HIF-1α ), a master transcriptional regulator of tissue hypoxic response which includes upregulation of 
VEGF40. A role of p66shc in vascular homeostasis and in particular in (micro- and macro-) vascular disorders 
associated with oxidative stress has been convincingly demonstrated51. Importantly, these disorders are typical 
of ageing-associated diseases like atherosclerosis and diabetic complications23. In a current model, p66-triggered 
mitochondrial ROS reduce NO bioavailability and produce highly reactive peroxynitrite, leading to impaired vas-
orelaxation, accumulation of oxidative damage and vascular inflammation, that further contributes to decreased 
blood flow. Our findings, including blunted oxidative stress and reduced (although not abrogated) VEGF levels in 
noise-exposed p66KO mice, clearly suggest that p66shc may be responsible of a robust albeit transient phenome-
non of cochlear vascular dysfunction that dramatically impairs auditory function few hours after noise exposure 
in p66shc proficient animals.
We have also observed that p66 deletion delays the age-related auditory decline of 129SvEv, mice, with the 
maximum difference between p66-decifient animals and controls being evident at twelve month age. ARHL has 
been previously linked to disturbances of cochlear blood flow and to inflammatory changes of the cochlea30,38,39. 
Therefore, although cochleae have not been analyzed in the context of the ARHL experiments, it is conceivable 
that, like in other models of age-related disease, beneficial effects of p66shc ablation on ARHL reflect, at least in 
part, a better preserved vascular function. Thus, the same p66shc-centered pathogenic circuitry involving oxida-
tive stress, vascular dysfunction with inflammatory changes and cochlear ischemia may underlie both NIHL and 
ARHL in 129SvEv mice. Noteworthy, literature evidence and our own data indicate that this mouse strain displays 
a remarkable resistance to noise-induced permanent hearing loss44,45. Thus, the transient/temporary auditory loss 
that we were able to detect in a very narrow temporal window of sensitivity after trauma, may represent a specific 
component of NIHL that shares its pathogenic mechanism (i.e. vascular dysfunction) with ARHL, to which these 
mice are instead prone44.
Finally, the bulk of data from the murine and rat model connects p66shc action to biochemical evidence of 
inflammation. This emerging connection is particularly intriguing. In fact, a low grade chronic inflammatory 
reaction (parainflammation) is believed to underlie most age-related pathologic processes52 including ARHL41,53; 
our findings, while standing for a shared oxidative-inflammatory axis in NIHL and ARHL, suggest that the acti-
vation of such axis, beside or in the context of vascular dysfunction, may represent a common event downstream 
of p66shc and by extension a general link between p66shc, systemic ageing and reduced health-span. This attractive 
hypothesis deserves further validation in additional models of age-related disease and “inflammaging”54.
Materials and Methods
Chemicals. Common laboratory chemicals were from SIGMA, unless differently stated. Antibodies used are 
listed below in methods where appropriate.
Animals. Male Wistar rats with normal Preyer’s reflex and male mice SvEv129 p66shcA+/+ wild-type and 
p66shcA−/− (henceforth indicated as WT and p66KO respectively) were included in this study. To investigate 
NIHL we used two month old Wistar rats and two month old mice randomly divided into the following: A) 
rat control, animals that did not received any treatment (Ctrl n = 20); B) rat noise, animals exposed to acoustic 
trauma (Noise n = 26); C) WT control, animals that did not received any treatment (WT Ctrl n = 10); D) WT 
noise, animals exposed to acoustic trauma (WT Noise n = 16); E) p66KO control, animals that did not receive any 
treatment (p66KOCtrl n = 10); F) p66 KO noise, animals exposed to acoustic trauma (p66KO Noise n = 16). We 
also analyzed the trend of hearing loss in ARHL and we used WT and p66 KO mice at age 2, 7, 12 and 24 months 
(8 animals x group).
All efforts were made to minimize animal suffering and to reduce the number needed for the experiments in 
accordance with the European Community Council Directive of November 24, 1986 (86/609/EEC). All proce-
dures were performed in compliance with the Laboratory of Animal Care and Use Committee of the Catholic 
University, School of Medicine of Rome and were approved by the Italian Department of Health.
Auditory brainstem response (ABR) recordings. ABR recordings were performed to analyze the 
summed responses of the synchronous firing of auditory nerve fibers and auditory brainstem neurons. Before 
ABR recordings, the animals were mildly anesthetized (ketamine at 35 mg/kg and medetomidine at 0.25 mg/kg 
for rats; ketamine at 35 mg/kg and medetomidine at 0.5 mg/kg for mice) and placed in the anechoic room. Three 
stainless steel recording electrodes were subcutaneously inserted posterior to the tested pinna, vertex and con-
tralateral pinna. ABRs were collected using a computer-controlled TDT System 3 (Tucker-Davis Technologies, 
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Alachua, FL, USA) data acquisition system with real-time digital signal processing. Tone bursts ranging from 6 
to 32 kHz (rise/fall time, 2 ms; total duration, 2 ms; repetition rate, 21/s) were presented monaurally in an open 
field using a horn tweeter (Tucker-Davis Technologies). The responses were filtered (100–3000 Hz bandpass), 
digitized and averaged across 500 discrete samples at each frequency-level combination. ABRs were measured 
at 6–32 kHz frequencies for both species. ABRs were assessed bilaterally in all animals (mice and rats) to ensure 
normal hearing. ABRs were reassessed in NIHL-exposed animals at several time points (1, 3, 7 and 21 days) to 
evaluate the effect of noise and in aging mice (2, 7, 12 and 24 months) to monitor the age-dependent auditory 
decline. Thresholds were determined by decreasing tone intensity in 5 dB steps starting at 100 dB and decreasing 
to 0 dB or until a reliably scored ABR component was detected. Then, an ascending series of ABRs was gathered 
starting below this point and moving up in stimulus intensity55,56. Hearing loss was estimated by comparing ABR 
thresholds, recorded in the animals at day 0 (before the acoustic trauma), with ABR thresholds at the different 
time points (1, 3, 7 and 21 days) after the noise exposure. Thus, the ABR data are expressed in terms of threshold 
and threshold shift that represents the difference between the pre-noise and post-noise exposure values of each 
animal for NIHL experimental procedure for each group. In ARHL experiments, thresholds were compared dur-
ing the aging period.
ABR Latencies-Amplitude (Neural Transmission Times). ABR analysis for the study of latency and amplitude 
was performed in rats and mice used for NIHL study and in mice used for the ARHL experimental procedure 
(WT and p66KO). The rodents ABR is composed of four components (labeled from P1 to P4). These components 
reflect the neural activity chiefly from the auditory nerve (Fetoni et al.43). We analyzed the ABR waves at 6–32 kHz 
however, latency–intensity (L–I) and amplitude–intensity (A–I) curves were derived at 16 kHz frequency condi-
tion because, at this frequency, it is possible to have ABR recordings at the lowest intensity of stimulation. Thus 
this condition provides the clearest L–I and A–I curves. An experimenter blind to treatment conditions scored the 
latencies and amplitudes of the ABR waves. Another experimenter then checked the ABR scoring for reliability.
Noise exposure. Wistar rats or WT and p66KO mice were exposed to noise in the NIHL paradigm applying 
a standardized acoustic trauma model, used in previous papers (35;36). Rats were deeply anesthetized, placed 
in a sound-proof room and exposed for 60 min to a 120 dB SPL pure tone sound at a frequency of 10 kHz. The 
sound was symmetrically presented in open field by a two dome tweeter (TW340 × 0, Audax) positioned 10 cm 
in front of the animal’s head55,56. Mice were placed in the anechoic room and exposed to a 100 dB sound pressure 
level SPL for 90 min at 10 kHz. The sound was presented in an open field by a dome tweeter (TW340 × 0; Audax, 
Chateau du Loir, France) positioned at the center of the cage. The sound was generated and amplified as previ-
ously described in Fetoni et al. 2014.
Immunohistochemistry and double-labeling immunofluorescence. To assess noise-induced oxida-
tive stress we used 8-isoprostane immunostaining and Dihydroethidium (DHE) staining. p66shc involvement in 
NIHL was analyzed by anti p66shc and anti ser36-P-p66shc laboratory antibodies listed below. The animals of NIHL 
procedure were ABR tested before and 24 hours after noise exposure and then anesthetized and sacrificed with a 
lethal dose. The cochleae were quickly removed, and the samples were fixed with 4% paraformaldehyde in PBS at 
4 °C and a pH 7,5. Next, the cochleae were decalcified in 10% Ethylenediaminetetraacetic acid (EDTA) incubated 
for 48 h in 30% sucrose, embedded in OCT, and cryosectioned at a thickness of 6 μ m for mice and 12 μ m for rats 
(Cryostat CM 1950; SLEE, Nikon, TO Italy). For superoxide detection the cochlear specimens were incubated 
with 1 μ M DHE (Invitrogen D23107, Carlsbad, CA, USA) in PBS for 30 min at 37 °C and then coverslipped with 
an antifade medium (ProLong Gold, Invitrogen P36930). For the immunofluorescence analyses, the slides were 
incubated in a blocking solution containing 1% BSA, 0.5% Triton X-100, and 10% normal goat serum in PBS 
for 1 h at room temperature and then incubated overnight at 4 °C with a solution containing primary antibod-
ies (mouse monoclonal anti-p66shc [LifeSpan Bioscience, WA, USA]), anti ser36-P-p66shc [Clone 6E10, Alexis, 
CA, USA] and anti HIF1α [Novus Bio, CO, USA], all 1:50 dilution in PBS; rabbit polyclonal anti 8-isoprostane 
[Oxford Biomedical Research, MI, USA] 1:100 and anti-VEGF-A ([Bioss Massachusetts, USA], 1:100 dilution 
in PBS). These antibodies cross reacted with mouse and rat tissues. At the end of the incubation, all slides were 
washed twice in PBS and incubated at room temperature for 2 h in the dark with secondary reagents (donkey 
anti-mouse (Alexa Fluor 546) or goat anti-rabbit (Alexa Fluor 633 or 488, IgG; Invitrogen, MI, Italy) diluted 1:400 
in 0.1 M PBS. After another wash in PBS, samples were double stained with DAPI (1:500) for 15 min in the dark 
at room temperature. Images of anti 8-isoprostane, anti-p66shc, anti ser36-P-p66shc, anti-HIF1α (hypoxia induced 
factor) and anti-VEGF-A (vascular endothelial growth factor) immuno-labeled specimens were taken by fluores-
cence microscope (Olympus BX63, MI, Italy) and confocal microscope (TCSSP2, Leica, Germany). For HIF1α 
confocal Z-stacks, series of 15–20 μ m-thick were acquired as images of 1024 × 1024 pixels, reordered at intervals 
of 0.5 μ m, in order to evaluate the real extent of the nuclear and/or cytoplasmatic fluorescence in high magnifica-
tions (40× ) of SGNs and StV . The optical density analysis was performed to quantify 8-isoprostane, DHE, p66shc, 
ser36-P-p66shc and VEGF-A fluorescence signals (LCS Lite, Leica Confocal Software)33.
Control experiments were performed by omitting the primary antibody during processing of tissue randomly 
selected across experimental groups. Staining was absent in the hair cells (HCs) and SGNs, indicating neither 
spontaneous fluorescence nor non specificity of antibody. Tissues from all groups were always processed together 
during the procedures to limit variability related to antibody penetration, incubation time, post-sectioning age, 
and condition of tissue.
Western blot analysis. Cochleae were quickly removed from the skull, the tympanic bulla was exposed, 
and the bony capsule of the cochlea and the lateral wall tissues were removed under stereomicroscope. The spec-
imens from each group included the modiolus and the organ of Corti. They were collected on ice and stored 
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at − 80 °C. The cochleae were rinsed and minced in PBS, put in plastic tubes and disaggregated with a tissue 
homogenizer in PBS containing protease inhibitor, Homogenates were clarified by centrifugation at 18.500 g and 
assayed for protein content by a modified Lowry method, using a commercial kit (Priotein DC, BIORAD, MI, 
Italy) according to the manufacturer’s recommendations. For western blot analysis, equal amounts of protein 
samples were resolved by SDS–PAGE, and electrotransferred onto nitrocellulose (Protran BA 85, Whatman® , 
GE Healthcare). Equal protein loading throughout the lanes was verified by reversible Ponceau-S staining. After 
2 hours blocking in TBS-T containing 5% w/v dry skim milk, membranes were incubated with the primary rea-
gent (anti ser36-P-p66shc, 1:1000 dilution in TBS-T + 3% dry milk) for 16 hours at 4 °C. Immuno-complexes were 
visualized by a HRP-conjugates goat anti mouse antiserum followed by ECL detection. Autoradiograms were 
acquired using a Gel. DOC Imaging Station (BIORAD) equipped with a dedicated Software (QuantityOne), and 
background-subtracted band intensity quantified by the Image-J software17.
Cytokine assay. Cytokine profiling of rat cochlear homogenates was performed by a commercial cytokine 
antibody array kit (Rat Cytokine Array C2, RayBiotech, Inc., Norcross, GA, USA), according to manufacturer’s 
recommendations. Briefly, 1 mg protein homogenate (in 1 ml buffer) was incubated with the array membrane at 
4 °C for 16 hours; after 4 washes, the biotinylated antibody cocktail solution was added for 2 hours at RT under 
continuous rocking. After removal of excess antibody and four additional washes immunocomplexes were visu-
alized by Streptavidin-HRP followed by Enhanced Chemoluminescence and autoradiography. Spots were quan-
tified on digital images by the ImageJ software. Each Spot volume (area x mean intensity) was subtracted of the 
nearby background signal. For each spot of the array a ratio Noise/Sham was calculated, and ratios were further 
normalized for the ratio between Positive control spots to account for membrane-to-membrane signal differ-
ences. Averages of duplicate spots were calculated, and Ratios > 1.5 or < 0.66 (1.5 fold reduction) were considered 
significant.
Statistical analysis. The results are presented as means ± standard deviation (SD) or standard error of the 
mean (SEM). ABR data were analyzed by means of three-way ANOVA (group/genotype x day x frequency); or 
two-way ANOVAs (group/genotype x frequency or time point x frequency). Latency and amplitude data were 
analyzed by means of two-way ANOVAs (group/genotype x decibels). When ANOVA showed significant differ-
ences, pair-wise comparisons between means were tested by Tukey’s post hoc testing (Statistica; Statsoft, USA). 
Western blot data were analyzed using unpaired two-tailed Student’s t-test. In all analyses, p < 0.05 was consid-
ered statistically significant.
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